Sign In
Buy CNS
$70.20
-1.00 (-1.40%)
At Close: Jun 03, 2026
RNP: Predictable Income From Cohen & Steers
06:28pm, Tuesday, 26'th Nov 2024
Cohen & Steers REIT & Preferred Income Fund offers a consistent monthly dividend, is managed by a professional team, and is diversified across REITs, preferred stocks, and fixed income. The RNP closed
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
05:59pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources o
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
05:58pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of t
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
05:56pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the so
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
05:52pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources o
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
05:51pm, Tuesday, 26'th Nov 2024
NEW YORK , Nov. 26, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dis
Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024) Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first hal
CORERO NETWORK SECURITY TAPS INDUSTRY VETERAN JUDSON THUERK TO LEAD CHANNEL STRATEGY IN THE AMERICAS
07:00am, Monday, 25'th Nov 2024
MARLBOROUGH, Mass. , Nov. 25, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) protection specialists, announces the addition of Judso
HOUSTON, TX / ACCESSWIRE / November 18, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
09:10am, Friday, 15'th Nov 2024
Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025 Company strengthens cash position to extend runway to fund operations beyond da
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For October 2024
04:23pm, Monday, 11'th Nov 2024
NEW YORK , Nov. 11, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $89.7 billion as of October 31, 2024, a decrease of $2.0 billion from as
Cohen & Steers Announces Changes to Realty Indexes
04:05pm, Friday, 08'th Nov 2024
NEW YORK , Nov. 8, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio In
Cohen & Steers Appoints Karen Wilson Thissen to Board of Directors
08:00am, Friday, 08'th Nov 2024
NEW YORK , Nov. 8, 2024 /PRNewswire/ -- Cohen & Steers, Inc.'s (NYSE: CNS) Board of Directors has appointed Karen Wilson Thissen as a director of the company. Ms. Thissen has also been appointed as a
Cohen & Steers, Inc. Declares Quarterly Dividend
04:24pm, Thursday, 07'th Nov 2024
NEW YORK , Nov. 7, 2024 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the fourth quarter of 2024 in the amount of $0.59 per share of common
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024
08:00am, Wednesday, 06'th Nov 2024
CUPERTINO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies
